Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients

The survival benefit of adjuvant radiotherapy in T4 colon cancer (CC) remains controversial, with conflicting results reported in the literature. This study aimed to explore the relationship between pretreatment carcinoembryonic antigen (CEA) level and overall survival (OS) of pT4N+ CC patients trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Dakui, Zhang, Ruoxin, Yang, Yufei, Li, Qingguo, Li, Xinxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950319/
https://www.ncbi.nlm.nih.gov/pubmed/36844877
http://dx.doi.org/10.1155/2023/4815996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950319/
https://www.ncbi.nlm.nih.gov/pubmed/36844877
http://dx.doi.org/10.1155/2023/4815996

Ejemplares similares